Terrie Curran, Director at Myovant Sciences Ltd. (MYOV), sold 85,643 shares at $25.00 ($2.1M) on 2021-09-01, disclosed to the SEC on 2021-09-03.
Open-market sale of $2.1M MYOV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 11,373 | $284K | 13.3% |
| 2 | $25.03 | 37,135 | $929K | 43.4% |
| 3 | $25.03 | 37,135 | $929K | 43.4% |
| Total | $25.03 avg | 85,643 | $2.1M | 100% |
| Filing → |
| PHAT | SELL | 2025-01-23 | $252K | — | Filing → |
| ARQT | SELL | 2024-11-13 | $189K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $793K | — | Filing → |